Back to ZACKS INVESTMENT MANAGEMENT ZACKS INVESTMENT MANAGEMENT

TRVITRVI
2 quarters

Position history for ZACKS INVESTMENT MANAGEMENTZACKS INVESTMENT MANAGEMENT's holdings in Trevi Therapeutics, Inc.

ZACKS INVESTMENT MANAGEMENT previously held 0 shares of TRVI (Trevi Therapeutics, Inc.), worth $0 as of 2023-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$23,900

Total Shares Change

-10,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2023-Q3
Latest
Exited
0
-100.0%
$00.0%$2.18
0
2023-Q2
New
10,000
-
$23,9000.0%$2.28
26

Other major holders of TRVI: FMR LLC, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used